MedTrace Logo

Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer

NCT02486796 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-08-01

Study results available
· View outcomes & findings →

Summary

This study is examine the effect of the addition of naturopathic on immunologic and/or inflammatory parameters and/or quality of life in women receiving neoadjuvant chemotherapy for breast cancer.

Conditions

  • Quality of Life

Interventions

BIOLOGICAL

Reishi mushroom extract

Reishi mushroom preparation produced water-ethanol extraction.

DRUG

Coenzyme Q10

Preparation of coenzyme Q10

DRUG

Melatonin

Preparation of melatonin

Sponsors & Collaborators

  • Midwestern Regional Medical Center

    lead OTHER

Principal Investigators

  • Christina Shannon, ND · Midwestern Regional Medical Center, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-19
Primary Completion
2017-03-03
Completion
2017-03-03
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02486796 on ClinicalTrials.gov